Türkkan Evrensel profile image
Türkkan Evrensel
Publication 7 Review 0
7 Publication
0 Review

Institution

Publications

Beyond conventional staging: prognostic significance of systemic inflammatory indices at diagnosis in malignant peripheral nerve sheath tumors
Authors: Sibel Oyucu Orhan , Bedrettin Orhan , Fatma Banu Demir , Seda Sali , Birol Ocak , Ahmet Bilgehan Şahin , Adem Deligönül , Erdem Çubukçu , Türkkan Evrensel
Published: 2026 , Turkish Journal of Clinics and Laboratory
DOI: 10.18663/tjcl.1860402
FAVORITE 0 TOTAL DOWNLOAD COUNT 103

0

103

Long-Term Survival of Cancer Patients Following COVID-19 Infection: Prognostic Value of Inflammatory Indices and Vaccination Status
Authors: Seda Sali , Mehmet Akif Ötegeçeli , Şule Özalp , Ahmet Bilgehan Şahin , Birol Ocak , Mürsel Sali , Eyüp Çoban , Burcu Caner , Sibel Oyucu Orhan , Adem Deligönül , Türkkan Evrensel , Erdem Çubukçu
Published: 2026 , Journal of Uludağ University Medical Faculty
DOI: 10.32708/uutfd.1898579
FAVORITE 0 TOTAL DOWNLOAD COUNT 85

0

85

The evaluation of the HSP70 and TCP1 status of circulating tumor cells derived from metastatic colorectal cancer patients
Authors: Dilek Pirim , Berkcan Dogan , Fatih Atilla Bağcı , Özgen Işık , Türkkan Evrensel
Published: 2025 , Deneysel ve Klinik Tıp Dergisi
DOI: -
FAVORITE 0 TOTAL DOWNLOAD COUNT 143

0

143

A Retrospective Analysis of Topotecan Treatment in Small Cell Lung Cancer
Authors: Alper Coşkun , Eyüp Çoban , Seda Sali , Süreyya Sarıhan , Ahmet Bilgehan Şahin , Adem Deligönül , Erdem Çubukçu , Türkkan Evrensel
Published: 2025 , Journal of Uludağ University Medical Faculty
DOI: 10.32708/uutfd.1742951
FAVORITE 0 TOTAL DOWNLOAD COUNT 291

0

291

HER2-Low Expression Predicts Improved Pathologic Response but not Disease-Free Survival in HR-Positive/HER2-Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Authors: Ahmet Bilgehan Şahin , Cagla Karaoglu , Mursel Sali , Buket Erkan Ozmarasali , Ender Eren Özçelik , Yagmur Karaman , Gul Akın , Hulya Odabası Bukun , Ali Aktas , Mine Özşen , Birol Ocak , Adem Deligönül , Erdem Çubukçu , Türkkan Evrensel
Published: 2025 , Journal of Uludağ University Medical Faculty
DOI: -
FAVORITE 0 TOTAL DOWNLOAD COUNT 320

0

320

Single Center Cetuximab Experience in Head and Neck Cancers
Authors: Seda Sali , Muhammed Abdurrahman Çelik , Alper Coşkun , Eyüp Çoban , Birol Ocak , Ahmet Bilgehan Şahin , Adem Deligönül , Erdem Çubukçu , Türkkan Evrensel
Published: 2025 , Journal of Uludağ University Medical Faculty
DOI: 10.32708/uutfd.1510864
FAVORITE 0 TOTAL DOWNLOAD COUNT 461

0

461

Prognostic factors in atypical carcinoid tumors
Authors: Ahmet Bilgehan Şahin , Erdem Çubukçu , Adem Deligönül , Birol Ocak , Huseyin Melek , Buket Erkan Ozmarasali , Burcu Caner , Ahmet Bayram , Elif Ülker Akyıldız , Türkkan Evrensel
Published: 2023 , The European Research Journal
DOI: 10.18621/eurj.1345267
FAVORITE 0 TOTAL DOWNLOAD COUNT 903

0

903

Articles published in
Deneysel ve Klinik Tıp Dergisi
Deneysel ve Klinik Tıp Dergisi
Journal of Uludağ University Medical Faculty
Journal of Uludağ University Medical Faculty
The European Research Journal
The European Research Journal
Turkish Journal of Clinics and Laboratory
Turkish Journal of Clinics and Laboratory
User doesn't have any peer review duties on DergiPark.
There are no Crossref cited.
Popular Publications: It is determined automatically by the researchers doing research in DergiPark according to the statistics of being added to the favorites. CrossRef Cited: The citations shown in DergiPark are drawn from CrossRef. For this, the cited and cited articles must be registered in CrossRef (DOI number). ^: Citation numbers are reflected in the system by DergiPark at certain periods.